The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Abstract
Prostanoids are a group of bioactive lipids working as local mediators and include D, E, F and I types of prostaglandins (PGs) and thromboxanes. Prostacyclin (PGI2) acts on platelets and blood vessels to inhibit platelet aggregation and to cause vasodilatation, and is thought to be important for vascular homeostasis. Aspirin-like drugs, including indomethacin, which inhibit prostanoid biosynthesis, suppress fever, inflammatory swelling and pain, and interfere with female reproduction, suggesting that prostanoids are involved in these processes, although it is not clear which prostanoid is the endogenous mediator of a particular process. Prostanoids act on seven-transmembrane-domain receptors which are selective for each type. Here we disrupt the gene for the prostacyclin receptor in mice by using homologous recombination. The receptor-deficient mice are viable, reproductive and normotensive. However, their susceptibility to thrombosis is increased, and their inflammatory and pain responses are reduced to the levels observed in indomethacin-treated wild-type mice. Our results establish that prostacyclin is an antithrombotic agent in vivo and provide evidence for its role as a mediator of inflammation and pain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, M. J., & de Beer, E. J. (1959) · Cited by 2,671
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, W. N., & de Beer, E. J. (1959) · Medical Entomology and Zoology · Cited by 2,132
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108 · cited 1×
“The generation of chimaeras and mutant mice has been describe”
BackgroundSelf-citationProstaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082 · cited 1×
“A similar abnormal mendelian ratio of male F 2 progeny was reported for cyclooxygenase-2-deficient mic”
BackgroundMalmberg, A. B., & Yaksh, T. L. (1992) · Science · doi:10.1126/science.1381521 · Cited by 710 · cited 1×
“but also by facilitating pain transmission at the spina”
BackgroundThe Role of Arachidonic Acid Oxygenation Products in Pain and Inflammation
Davies, P. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.335 · Cited by 467
Rat model of arterial thrombosis induced by ferric chloride
Kurz, K. D., Main, B. W., & Sandusky, G. E. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90106-m · Cited by 431 · cited 1×
“5% FeCl 3 solution, a procedure known to injure the endotheliu”
Background
Cited by
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,412
Self-citationThe induction of pain: an integrative review
Millan, M. J. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00048-3 · Cited by 1,774
“Interestingly, PGI2-de®cient, transgenic mice were recently shown to display a reduction in peripheral in ̄ammation and nociception, consistent with a role of PGI2 in mediating nociception (Murata et al., 1997).”
BackgroundCyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
“ministration of dilute acetic acid (Murata et al., 1997).”
BackgroundInfluentialThe Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Eicosanoid storm in infection and inflammation
Dennis, E. A., & Norris, P. C. (2015) · Nature Reviews Immunology · doi:10.1038/nri3859 · Cited by 1,517
Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient Mice
Lim, H., Paria, B. C., Das, S. K., Dinchuk, J. E., Langenbach, R., Trzaskos, J. M., & Dey, S. K. (1997) · Cell · doi:10.1016/s0092-8674(00)80402-x · Cited by 1,430
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., García Rodríguez, L. A., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,218
Sugimoto, Y., & Narumiya, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600038200 · Cited by 1,196
Self-citationSelexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R., Chin, K. M., Frey, A., Gaine, S., Galiè, N., Ghofrani, H.-A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,060
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Hata, A. N., & Breyer, R. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.003 · Cited by 840
“permeability (Murata et al., 1997) Stimulation of T-cell IL-10 production”
BackgroundInfluentialRole of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., & FitzGerald, G. A. (2002) · Science · doi:10.1126/science.1068711 · Cited by 789
Patrono, C., Baigent, C., Hirsh, J., & Roth, G. (2008) · Chest · doi:10.1378/chest.08-0672 · Cited by 748
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113416 · Cited by 726
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13416 · Cited by 725
“Studies by Murata and colleagues showed that inflammatory pain responses are significantly reduced in mice lacking prostacyclin (IP) receptors, suggesting that IP receptors play a major role in the prostanoid-dependent component of pain (32).”
BackgroundInfluentialProstaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?
Wallace, J. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00004.2008 · Cited by 716
“This could have therapeutic implications if it occurs when a selective inhibitor of mPGES-1 is used on a chronic basis; for example, prostacyclin has been implicated as a mediator of pain (132).”
BackgroundImpaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677
“Mice lacking the EP 1 or EP 3 receptors were generated nearly as describe”
MethodSelf-citationCarson, D. D., Bagchi, I., Dey, S. K., Enders, A. C., Fazleabas, A. T., Lessey, B. A., & Yoshinaga, K. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9767 · Cited by 676
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
Patrono, C., Coller, B., FitzGerald, G. A., Hirsh, J., & Roth, G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.234s · Cited by 671
Heritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception
Mogil, J. S., Wilson, S. G., Bon, K., Eun Lee, S., Chung, K., Raber, P., Pieper, J. O., Hain, H. S., Belknap, J. K., Hubert, L., et al. (1999) · Pain · doi:10.1016/s0304-3959(98)00197-3 · Cited by 656
“Some existing KO studies of pain (see Mogil and Grisel, 1998) are potentially subject to this concern based on the present data (Malmberg et al., 1997a,b; Murata et al., 1997; Robertson et al., 1997).”
Marceau, F., Hess, J. F., & Bachvarov, D. R. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01371-1 · Cited by 602
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
“However, Narumiya and coworkers (Murata et al., 1997) have reported that inactivation of the prostacyclin receptor gene results in an increased susceptibility to thrombosis in vivo.”
Synopsis of arachidonic acid metabolism: A review
Hanna, V. S., & Hafez, E. A. A. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.03.005 · Cited by 596
Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta
Lim, H., Gupta, R. A., Ma, W.-G., Paria, B. C., Moller, D. E., Morrow, J. D., DuBois, R. N., Trzaskos, J. M., & Dey, S. K. (1999) · Genes & Development · doi:10.1101/gad.13.12.1561 · Cited by 587
“However, this gene is apparently not critical in reproduction, as both female and male homozygous null mutant mice for IP are fertile (Murata et al. 1997).”
BackgroundThe Hemostatic System as a Modulator of Atherosclerosis
Borissoff, J. I., Spronk, H. M. H., & ten Cate, H. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011670 · Cited by 569
Genetic and pharmacological analysis of prostanoid receptor function
Narumiya, S., & FitzGerald, G. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13455 · Cited by 568
Self-citationSensitization of TRPV1 by EP1 and IP Reveals Peripheral Nociceptive Mechanism of Prostaglandins
Moriyama, T., Higashi, T., Togashi, K., Iida, T., Segi, E., Sugimoto, Y., Tominaga, T., Narumiya, S., & Tominaga, M. (2005) · Molecular Pain · doi:10.1186/1744-8069-1-3 · Cited by 544
“The role of IP in inflammation has been clearly shown by the analysis of IP-deficient mice, although the underlying cellular mechanisms still remain to be elucidated [8].”
BackgroundMethodSelf-citationWeitz, J. I., Eikelboom, J. W., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2294 · Cited by 527
COX-2 and beyond: approaches to prostaglandin inhibition in human disease
FitzGerald, G. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1225 · Cited by 518
“However, deletion of IP does increase the response to thrombotic stimuli in vivo”
BackgroundPlatelets at work in primary hemostasis
Broos, K., Feys, H. B., De Meyer, S. F., Vanhoorelbeke, K., & Deckmyn, H. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.03.002 · Cited by 502
New insights into the use of currently available non-steroidal anti-inflammatory drugs
Brune, & Patrignani, P. (2015) · Journal of Pain Research · doi:10.2147/jpr.s75160 · Cited by 469
“34,36 Peripheral inflammation is also associated with upregulation of COX-2 and an increase in PGE 2 in the central nervous system, while contributing to the development of central hyperalgesia.”
Phillis, J. W., Horrocks, L. A., & Farooqui, A. A. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.02.002 · Cited by 459
Cyclooxygenase-2 Controls Energy Homeostasis in Mice by de Novo Recruitment of Brown Adipocytes
Vegiopoulos, A., Müller-Decker, K., Strzoda, D., Schmitt, I., Chichelnitskiy, E., Ostertag, A., Diaz, M. B., Rozman, J., Hrabe de Angelis, M., Nüsing, R. M., et al. (2010) · Science · doi:10.1126/science.1186034 · Cited by 459
Woodward, D. F., Jones, R. L., & Narumiya, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003517 · Cited by 443
“As for inflammatory swelling, Murata et al. (1997) subjected IP-deficient mice to the carrageenininduced paw swelling model and found that inflammatory swelling was reduced by 50% in these animals, an effect similar in magnitude to that achieved by treatment of wild-type mice with nonsteroidal…”
BackgroundResultInfluentialSelf-citationArachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases
Sonnweber, T., Pizzini, A., Nairz, M., Weiss, G., & Tancevski, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113285 · Cited by 440
COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice
Egan, K. M., Lawson, J. A., Fries, S., Koller, B., Rader, D. J., Smyth, E. M., & FitzGerald, G. A. (2004) · Science · doi:10.1126/science.1103333 · Cited by 431
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214459 · Cited by 418
Self-citationThrombin and Platelet Activation
Brass, L. F. (2003) · Chest · doi:10.1378/chest.124.3_suppl.18s · Cited by 404
Eikelboom, J. W., Hirsh, J., Spencer, F. A., Baglin, T. P., & Weitz, J. I. (2012) · Chest · doi:10.1378/chest.11-2293 · Cited by 379
Cyclooxygenase-1 and -2–Dependent Prostacyclin Formation in Patients With Atherosclerosis
Belton, O., Byrne, D., Kearney, D., Leahy, A., & Fitzgerald, D. J. (2000) · Circulation · doi:10.1161/01.cir.102.8.840 · Cited by 377
The Essentiality of Arachidonic Acid in Infant Development
Hadley, K., Ryan, A., Forsyth, S., Gautier, S., & Salem, N. (2016) · Nutrients · doi:10.3390/nu8040216 · Cited by 373
“Prostaglandins are also involved in sleep regulation [105], febrile response [106], and in pain perception [107].”
BackgroundKobayashi, T., Tahara, Y., Matsumoto, M., Iguchi, M., Sano, H., Murayama, T., Arai, H., Oida, H., Yurugi-Kobayashi, T., Yamashita, J. K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421446 · Cited by 373
Self-citationEndothelium‐mediated control of vascular tone: COX‐1 and COX‐2 products
Félétou, M., Huang, Y., & Vanhoutte, P. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01276.x · Cited by 372
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh, M., Watanabe, K., Kitamura, T., Shoji, Y., Takahashi, M., Kawamori, T., Tani, K., Kobayashi, M., Maruyama, T., Kobayashi, K., et al. (2002) · PubMed · Cited by 362
Self-citationMolecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents
Tasneem, S., Liu, B., Li, B., Choudhary, M. I., & Wang, W. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.001 · Cited by 358
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.
Watanabe, K., Kawamori, T., Nakatsugi, S., Ohta, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Ushikubi, F., Narumiya, S., et al. (1999) · PubMed · Cited by 351
Self-citationGPR109A (PUMA-G/HM74A) mediates nicotinic acid–induced flushing
Benyó, Z., Gille, A., Kero, J., Csiky, M., Suchánková, M. C., Nüsing, R. M., Moers, A., Pfeffer, K., & Offermanns, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23626 · Cited by 340
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
Cheng, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27540 · Cited by 339
Mutant G-protein-coupled receptors as a cause of human diseases
Schöneberg, T., Schulz, A., Biebermann, H., Hermsdorf, T., Römpler, H., & Sangkuhl, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.008 · Cited by 337
Old and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 334
COX-2 Inhibitors and Cardiovascular Risk
Funk, C. D., & FitzGerald, G. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318157f72d · Cited by 330
“Absence of the prostacyclin receptor, known as IP, which transduces the effects of prostacyclin, augmented the response to a thrombogenic stimulus in mice.(115) In human coronary artery smooth muscle cells, prostacyclin stimulates thrombomodulin expression that constrains activation of the blood coagulant thrombin.”
BackgroundHost Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth
Amano, H., Hayashi, I., Endo, H., Kitasato, H., Yamashina, S., Maruyama, T., Kobayashi, M., Satoh, K., Narita, M., Sugimoto, Y., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021408 · Cited by 325
Self-citationEffects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans
Morris, T., Stables, M., Hobbs, A., de Souza, P., Colville-Nash, P., Warner, T., Newson, J., Bellingan, G., & Gilroy, D. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900477 · Cited by 322
“Finally, PGI2 (measured as 6-keto-PGF1 ) in plasma (H) and blister fluid (I) was reduced by aspirin, which despite causing edema formation in rodents (22), did not”
BackgroundNSAIDs and Cancer Prevention: Targets Downstream of COX-2
Cha, Y. I., & DuBois, R. N. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131253 · Cited by 308
Massiera, F., Saint-Marc, P., Seydoux, J., Murata, T., Kobayashi, T., Narumiya, S., Guesnet, P., Amri, E.-Z., Negrel, R., & Ailhaud, G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200346-jlr200 · Cited by 297
“The ip-r -null mice were established by gene targeting and backcrossed with C57/BL6J mice for at least 10 generations (28), then ip-r / males and ip-r / females were bred to generate further generations.”
MethodSelf-citationBiochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia
Fosslien, E. (2000) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360091174286 · Cited by 296
Pethő, G., & Reeh, P. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00048.2010 · Cited by 288
Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1
Kamei, D., Yamakawa, K., Takegoshi, Y., Mikami-Nakanishi, M., Nakatani, Y., Oh-ishi, S., Yasui, H., Azuma, Y., Hirasawa, N., Ohuchi, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400199200 · Cited by 279
Self-citationMitchell, J. A., & Warner, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1929 · Cited by 279
“Studies from mice lacking a functional receptor for prostacyclin suggest that the consequences of this may not be an increase in spontaneous thrombosis but an exaggerated response to pro-thrombotic stimul”
BackgroundProstaglandin E receptors and the kidney
Breyer, M. D., & Breyer, R. M. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.1.f12 · Cited by 274
Stichtenoth, D. O., Thorén, S., Bian, H., Peters-Golden, M., Jakobsson, P.-J., & Crofford, L. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.469 · Cited by 269
“It is currently unclear how much of the inflammation in human arthritis is mediated by PGE2; indeed, mice with a targeted deletion of the prostacyclin receptor have reduced pain and inflammation (37).”
BackgroundGuay, J., Bateman, K., Gordon, R., Mancini, J., & Riendeau, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403106200 · Cited by 268
Jang, Y., Kim, M., & Hwang, S. W. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1703-1 · Cited by 263
Burian, M., & Geisslinger, G. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.02.004 · Cited by 259
Prostaglandin E2 Receptor EP4 Contributes to Inflammatory Pain Hypersensitivity
Lin, C.-R., Amaya, F., Barrett, L., Wang, H., Takada, J., Samad, T. A., & Woolf, C. J. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105569 · Cited by 257
McAdam, B. F., Mardini, I. A., Habib, A., Burke, A., Lawson, J. A., Kapoor, S., & FitzGerald, G. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9523 · Cited by 253
“Experiments in knockout mice suggest that PGE2, acting via the EP3 receptor, mediates the pyrexial response to LPS (52), and PGI2 also appears important in mediating the pain and swelling evoked by inflammatory stimuli (53).”
BackgroundMajed, B. H., & Khalil, R. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004770 · Cited by 252
“In addition, 30% of the IP-deficient mice die within 1 day as a result of bilateral occlusions of the carotid arteries and/or embolic stroke, whereas wild-type mice survive this period (Murata et al., 1997).”
BackgroundSong, H., Lim, H. J., Das, S., Paria, B. C., & Dey, S. K. (2000) · Molecular Endocrinology · doi:10.1210/me.14.8.1147 · Cited by 249
“Furthermore, mice deficient in PGI2 cell surface receptor (IP) or PGF2a receptor (FP) do not exhibit overt implantation defects (68, 69).”
BackgroundReproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor
Tilley, S. L., Audoly, L. P., Hicks, E. H., Kim, H.-S., Flannery, P. J., Coffman, T. M., & Koller, B. H. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6579 · Cited by 249
“Decreased implantation or decidualization was not reported for the FP-, IP-, or TP-receptor–deficient mice (11, 12, 21).”
BackgroundPhysiological Regulation of Prostaglandins in the Kidney
Hao, C.-M., & Breyer, M. D. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100614 · Cited by 247
Cyclooxygenase inhibitors: From pharmacology to clinical read-outs
Patrignani, P., & Patrono, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.016 · Cited by 239
“In fact, prostanoids increase neuronal activity in nociceptive nerve fibers by lowering the activation threshold for opening sodium channels in the neuronal membrane [65,66].”
BackgroundMancini, J. A., Blood, K., Guay, J., Gordon, R., Claveau, D., Chan, C.-C., & Riendeau, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006865200 · Cited by 246
Peripheral gating of pain signals by endogenous lipid mediators
Piomelli, D., & Sasso, O. (2014) · Nature Neuroscience · doi:10.1038/nn.3612 · Cited by 246
“The key roles that two such mediators, prostaglandin E 2 (PGE 2 ) and prostacyclin (PGI 2 ), play in nociceptor sensitization were first identified in the 1970s 4 and are now firmly established 5 .”
Cytokine control in human endometrium
Kelly, R. W., King, A. E., & Critchley, H. O. (2001) · Reproduction · doi:10.1530/rep.0.1210003 · Cited by 239
“A study in which the prostacyclin (PGI) receptor was ablated in mice showed that such animals had a higher pain threshold (Murata et al., 1997) and, although little PGI is synthesized in human endometrium (Abel and Kelly, 1979), this effect might be relevant to menstrual pain originating in myometrium, where PGI is th…”
BackgroundClapp, L. H., Finney, P. A., Turcato, S., Tran, S., Rubin, L. J., & Tinker, A. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.2.4695 · Cited by 235
The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure
Stock, J. L., Shinjo, K., Burkhardt, J., Roach, M., Taniguchi, K., Ishikawa, T., Kim, H.-S., Flannery, P. J., Coffman, T. M., McNeish, J. D., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci6749 · Cited by 235
“Studies by Murata and colleagues using mice lacking prostacyclin receptors (IP) have also suggested that IP receptors play a large role in this response (29).”
BackgroundEmotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
Grosser, T., Yu, Y., & FitzGerald, G. A. (2010) · Annual Review of Medicine · doi:10.1146/annurev-med-011209-153129 · Cited by 232
“Deletion of the IP resulted in an augmented thrombotic response (51, 52) and intimal hyperproliferation (52) in response to vascular injury.”
BackgroundFélétou, M. (2011) · Colloquium Series on Integrated Systems Physiology: From Molecule to Function · doi:10.4199/c00031ed1v01y201105isp019 · Cited by 200
G Protein–Coupled Prostanoid Receptors and the Kidney
Breyer, M. D., & Breyer, R. M. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.579 · Cited by 226
Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action
Ayoub, S. S. (2021) · Temperature · doi:10.1080/23328940.2021.1886392 · Cited by 223
“In IP-receptor knockout mice, it was demonstrated that no constriction responses were induced in response to acetic acid [49].”
BackgroundPraticò, D., Tillmann, C., Zhang, Z.-B., Li, H., & FitzGerald, G. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061607398 · Cited by 215
Honda, T., Segi-Nishida, E., Miyachi, Y., & Narumiya, S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051310 · Cited by 208
“Using mice lacking the IP, we previously showed the role of PGI2 as a mediator of acute infl ammation induced by bradykinin or carrageenin, and of acute pain response to acetic acid (16).”
Self-citationRaging the War Against Inflammation With Natural Products
Attiq, A., Jalil, J., Husain, K., & Ahmad, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00976 · Cited by 211
Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis
Wang, M., Zukas, A. M., Hui, Y., Ricciotti, E., Puré, E., & FitzGerald, G. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606586103 · Cited by 205
Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development
Robichaux, W. G., & Cheng, X. (2018) · Physiological Reviews · doi:10.1152/physrev.00025.2017 · Cited by 208
Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype
Reinold, H., Ahmadi, S., Depner, U. B., Layh, B., Heindl, C., Hamza, M., Pahl, A., Brune, K., Narumiya, S., Müller, U., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23618 · Cited by 202
“the deficits in peripheral inflammatory pain sensitization observed in EP1 receptor– or IP receptor–deficient mice (8, 10).”
BackgroundSelf-citationThe role of IP prostanoid receptors in inflammatory pain
Bley, K. R., Hunter, J. C., Eglen, R. M., & Smith, J. A. M. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01185-7 · Cited by 200
Role of G protein-coupled receptors in inflammation
Sun, L., & Ye, R. D. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.200 · Cited by 191
Ito, S., Okuda-Ashitaka, E., & Minami, T. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00289-9 · Cited by 198
Dirig, D. M., Isakson, P. C., & Yaksh, T. L. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37497-x · Cited by 205
“, 1996) or gene disruption of the prostacyclin receptor in mice (Murata et al., 1997).”
Xiao, C.-Y., Hara, A., Yuhki, K.-I., Fujino, T., Ma, H., Okada, Y., Takahata, O., Yamada, T., Murata, T., Narumiya, S., et al. (2001) · Circulation · doi:10.1161/hc4301.098058 · Cited by 197
Self-citationAntzelevitch, C., Brugada, P., Brugada, J., Brugada, R., Towbin, J. A., & Nademanee, K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00310-3 · Cited by 196
Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors
Katori, M., & Majima, M. (2000) · Inflammation Research · doi:10.1007/s000110050605 · Cited by 193
Inflammatory Pain: The Cellular Basis of Heat Hyperalgesia
Huang, J., Zhang, X., & McNaughton, P. (2006) · Current Neuropharmacology · doi:10.2174/157015906778019554 · Cited by 194
“Critical actions of EP and IP receptors in inflammation and pain were later demonstrated by behavioural studies of mice lacking IP, EP1 or EP3 receptors, where in all three cases, mice lacking one of these receptors showed a significant reduction in pain perception and thermal hyperalgesia [71,75,77,113].”
BackgroundEgan, K. M., Wang, M., Lucitt, M. B., Zukas, A. M., Puré, E., Lawson, J. A., & FitzGerald, G. A. (2005) · Circulation · doi:10.1161/01.cir.0000153386.95356.78 · Cited by 193
“A, En face quantification of percent lesion area of aortas from male Apobec-1/LDLR DKO mice fed 1% cholesterol diet (1) alone; (2) with MF tricyclic (15 mg/kg); (3) with 5 mg/kg S18886 in drinking water; or (4) supplemented with TP (S18886, 5 mg/kg), and COX-2 inhibitor (MF tricyclic, 15 mg/kg) shows reduction in lesi…”
Method
Metadata
- Authors
- Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S., & Narumiya, S.
- Affiliations
- Kyoto University (JP)
- Ono Pharmaceutical (Japan) (JP)
- Osaka Women's and Children's Hospital (JP)
- Kitasato University (JP)
- Corresponding author
- Narumiya, Shuh
- Venue
- Nature
- Published
- 1997-08-14
- Volume
- 388
- Issue
- 6643
- Pages
- 678-682
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1666619344
- Cited by
- 773
- References
- 27
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 14 · 2020: 15 · 2019: 21 · 2018: 14 · 2017: 23 · 2016: 18 · 2015: 29 · 2014: 17 · 2013: 21 · 2012: 33
- FWCI
- 25.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- prostacyclin receptor, prostacyclin, prostanoids, pain perception, inflammation, thrombosis, indomethacin, prostaglandins, thromboxane, knockout mice, antithrombotic agents, vascular homeostasis
- MeSH terms
- Animals, Antithrombins, Blood Pressure, Inflammation, Mice, Inbred C57BL, Pain, Platelet Aggregation, Epoprostenol, Receptors, Prostaglandin, Thrombosis, Restriction Mapping, Dinoprostone, Mutagenesis, Gene Targeting, Receptors, Epoprostenol, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.